Lux Capital Closes $245M Third Fund

  Lux Capital Closes $245M Third Fund

    New Fund Builds Upon Successful Investments in Energy, Technology and
                                 Healthcare;
                       Calls for Big, Bold, Brave Ideas

Business Wire

NEW YORK & PALO ALTO, Calif. -- February 13, 2013

Lux Capital (www.luxcapital.com), a leading venture capital firm, today
announced the closing of its third fund, Lux Ventures III, with commitments
totaling $245 million. The Fund was oversubscribed, surpassing its initial
$200 million target, and is the firm’s largest to date.Limited Partners
comprise a number of prominent global foundations, endowments, financial
institutions, fund-of-funds, corporations, and family offices.

“We are incredibly fortunate to have the support of our existing investors, as
well as welcoming new institutions as our partners in Lux Ventures III,”said
Lux Capital General Partner Adam Kalish. “We all share the philosophy that a
differentiated approach and willingness to make contrarian venture investments
can drive superior results.”

“At Lux, we are sticking to our knitting to build a concentrated portfolio of
extraordinary companies in unconventional areas,” said Lux Capital Co-Founder
and Managing Partner Josh Wolfe. “Many of the themes and entrepreneurs we’re
excited about—in 3D printing,metamaterials, robotics and breakthroughs in
solid-state electronics—are non-obvious, and that’s by design. We believe the
combination of brilliant entrepreneurs and deep scientific innovation drives
immense industry shifts and profits. Both at Lux and our companies, we’re
growing rapidly and calling for the boldest and brightest that want to invent
and invest in the future.”

Lux recently opened a new office in Palo Alto. The firm also added three new
Venture Partners to the team since raising its prior fund: Jeff Kindler,
former Chairman & CEO of Pfizer; Jim Woolsey, former Director of the CIA; and
Richard Foster, former Senior Partner at McKinsey.

Lux Ventures III is pursuing the same focused investment strategy within the
Energy, Technology and Healthcare sectors – investments revealed to date
includeGridcoSystems,Kymeta, Kyruus, andShapeways. The Fund is making seed
investments from $100,000 up to commitments of $15 million over a company’s
life. In addition to founding its own companies and backing brilliant
entrepreneurs from inception, Lux will also focus on special situations and
corporate spinouts. Lux’s prior fund Lux Ventures II closed in 2007,
allocating its nearly $100 million in commitments to representative
investments includingKurion,Transphorm, Cerulean,Genocea, Kala,
andEverspin.

"Lux has been a valuable forward-thinking partner and investor in helping
build Shapeways," said Peter Weijmarshausen, co-founder and CEO of Shapeways.
"Our motto is ‘Made in the Future’ and they're among the few actually
investing in it."

“Lux has taken a creative and methodical approach to build the next great
venture firm,” said Richard Robb, of CVF, LLC, an affiliate of Henry Crown &
Company. “By leveraging a novel platform and employing a unique investment
strategy, Lux is backing exciting companies and in the process has created a
very special firm.”

About Lux Capital Management

Lux Capital Management is a leading venture firm focused on founding, seed and
early stage investments in emerging technologies. Lux takes an active role in
helping entrepreneurs build successful businesses inEnergy, Technology and
Healthcare. The Lux investment team has founded more than 20 companies from
scratch, including Caliper, Genocea, Illumina, Kala, Kurion, Lux Research,
Nanosys, Neurocrine, and Vertex Pharmaceuticals.The firm is based in New York
and Palo Alto. For more information please visitwww.luxcapital.com

Contact:

Lux Capital
Peter Hebert, 650-681-0270
peter.hebert@luxcapital.com